MYND Life Sciences Inc.
MYND
CNSX
07/31/2024 | 04/30/2024 | 01/31/2024 | 10/31/2023 | 07/31/2023 | |
---|---|---|---|---|---|
Total Cash And Short-Term Investments | 300.00% | 85.71% | -- | -33.33% | -- |
Total Receivables | 8,500.00% | 2,959.76% | 433.30% | 494.59% | -95.09% |
Inventory | -- | -- | -- | -- | -- |
Prepaid Expenses | -- | -- | -- | -88.48% | -- |
Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
Other Current Assets | -14.29% | 57.69% | 11.76% | -- | -97.78% |
Total Current Assets | 3,547.54% | 2,192.83% | 426.89% | 225.30% | -97.09% |
|
|||||
Total Current Assets | 3,547.54% | 2,192.83% | 426.89% | 225.30% | -97.09% |
Net Property, Plant & Equipment | -80.93% | -80.51% | -94.35% | -94.44% | -82.88% |
Long-term Investments | -- | -- | -- | -- | -- |
Goodwill | -- | -- | -- | -- | -- |
Total Other Intangibles | -- | -- | -- | -- | -- |
Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
Total Other Assets | -68.26% | -- | -- | -- | -2.56% |
Total Assets | 100.62% | 95.86% | 40.10% | 19.70% | -66.13% |
|
|||||
Total Accounts Payable | -11.21% | -7.27% | 1.03% | 51.30% | 47.09% |
Total Accrued Expenses | 12.43% | 57.92% | 79.04% | 104.24% | 95.52% |
Short-term Debt | -3.75% | 6.10% | 13.65% | 18.72% | 322,228.57% |
Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Current | -- | -- | -- | -- | -- |
Total Finance Division Other Current Liabilities | 69.38% | 62.02% | 100.51% | 79.43% | 563.86% |
Total Other Current Liabilities | 69.38% | 62.02% | 100.51% | 79.43% | 563.86% |
Total Current Liabilities | 9.94% | 16.62% | 25.23% | 37.39% | 342.94% |
|
|||||
Total Current Liabilities | 9.94% | 16.62% | 25.23% | 37.39% | 342.94% |
Long-Term Debt | -- | -- | -- | -- | -- |
Short-term Debt | -3.75% | 6.10% | 13.65% | 18.72% | 322,228.57% |
Capital Leases | -- | -- | -- | -- | -- |
Finance Division Debt Non Current | -- | -- | -- | -- | -- |
Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
Total Other Liabilities | -- | -- | -- | -- | -- |
Total Liabilities | 9.94% | 16.62% | 24.04% | 35.44% | 47.62% |
|
|||||
Common Stock & APIC | -4.28% | 0.33% | 1.37% | -0.16% | -4.25% |
Retained Earnings | -0.41% | -5.92% | -11.57% | -16.84% | -30.70% |
Treasury Stock & Other | -4.79% | -1.34% | -0.30% | -1.86% | -2.62% |
Total Common Equity | -4.28% | -10.96% | -22.02% | -38.36% | -86.81% |
|
|||||
Preferred Stock Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
Preferred Stock Convertible | -- | -- | -- | -- | -- |
Preferred Stock, Others | -- | -- | -- | -- | -- |
Total Preferred Equity | -- | -- | -- | -- | -- |
|
|||||
Total Common Equity | -4.28% | -10.96% | -22.02% | -38.36% | -86.81% |
Total Preferred Equity | -- | -- | -- | -- | -- |
Total Minority Interest | -- | -- | -- | -- | -- |
Total Equity | -4.28% | -10.96% | -22.02% | -38.36% | -86.81% |
|